Table 4.
Health-Related Quality of Life Score Changes at Key Time Points in the Initial Treatment
| MID | Mean Δ T1→T2 (SD) | Patients mean Δ > MID | SRM T1→T2 | Mean Δ T2→T3 (SD) | Patients mean Δ > MID | SRMT2→T3 | Mean Δ T2→T3 (SD) | Patients mean Δ > MID | SRMT1→T3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EQ5Da | 0.052 | 0.022 (0.12) | 53% | 0.185 | (−0.027) (0.12) | 48% | −0.229 | (−0.003) (0.11) | 41% | −0.031 |
| SF6D | 0.027 | 0.038 (0.13) | 81% | 0.286 | (−0.049) (0.13) | 80% | −0.372 | (−0.005) (0.12) | 74% | −0.046 |
| HUI2 | 0.045 | 0.008 (0.14) | 59% | 0.055 | (−0.006) (0.09) | 61% | −0.059 | 0.012 (0.12) | 58% | 0.097 |
| HUI3 | 0.032 | 0.021 (0.19) | 63% | 0.112 | (−0.014) (0.15) | 67% | −0.091 | 0.019 (0.16) | 60% | 0.121 |
a
For the EQ5D-5L (0.5 × SD pre-op) considered threshold for MID.
MID, minimal important difference; SRM, standardized response mean; T1, pretreatment; T2, postoperative; T3, follow-up.